Suchergebnisse - (Person:"Lu, Qiong")

PubPharm (6)

1

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

2

Analysis of SARS-CoV-2 variants B.1.617 : host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity

enthalten in: Emerging microbes & infections | 2022

von Zhang, L. | Li, Q. | Wu, J. | +19

3

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

enthalten in: Signal transduction and targeted therapy | 2022

von Li, Q. | Zhang, L. | Liang, Z. | +13

4

The molecular basis for SARS-CoV-2 binding to dog ACE2

enthalten in: Nature communications | 2021

von Zhang, Z. | Zhang, Y. | Liu, K. | +19

5

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

enthalten in: Emerging microbes & infections | 2020

von Nie, J. | Li, Q. | Wu, J. | +15

6

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

enthalten in: Cell | 2020

von Li, Q. | Wu, J. | Nie, J. | +17

CommentIn: Signal Transduct Target Ther. 2020 Sep 3;5(1):185. - PMID 32883949

1
[1]